NASDAQ: STOKStoke Therapeutics Inc Stock Ownership - Who owns Stoke Therapeutics?
Insider buying vs selling
Have Stoke Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Trust Skorpios | 10% Owner | 2024-04-17 | 3,600,000 | $11.60 | $41.76MSell |
| Barry Ticho | CHIEF MEDICAL OFFICER | 2024-04-01 | 442 | $0.60 | $265.20Buy |
| Huw M. Nash | COO CBO | 2024-04-01 | 400 | $13.61 | $5.44kSell |
| Huw M. Nash | COO CBO | 2024-04-01 | 60,929 | $13.23 | $805.79kSell |
| Huw M. Nash | COO CBO | 2024-04-01 | 50,000 | $0.40 | $20.00kBuy |
| Barry Ticho | CHIEF MEDICAL OFFICER | 2024-04-01 | 9,426 | $13.23 | $124.69kSell |
| Jonathan Allan | GENERAL COUNSEL CORP SEC | 2024-03-28 | 100 | $13.81 | $1.38kSell |
| Jonathan Allan | GENERAL COUNSEL CORP SEC | 2024-03-28 | 5,026 | $13.19 | $66.29kSell |
| Stephen J. Tulipano | CFO | 2024-03-19 | 4,116 | $6.10 | $25.10kSell |
| Jonathan Allan | GENERAL COUNSEL CORP SEC | 2024-03-19 | 2,349 | $6.10 | $14.33kSell |
STOK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when STOK insiders and whales buy or sell their stock.
STOK Shareholders
What type of owners hold Stoke Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Seth Loring Harrison | 73.32% | 33,948,426 | $381.92M | Insider |
| Apple Tree Partners Iv LP | 37.06% | 17,161,713 | $193.07M | Insider |
| Skorpios Trust | 31.19% | 14,443,681 | $162.49M | Institution |
| Trust Skorpios | 23.42% | 10,843,681 | $121.99M | Insider |
| Rtw Investments LP | 8.92% | 4,131,045 | $46.47M | Institution |
| Cowen And Company LLC | 8.04% | 3,721,659 | $41.87M | Institution |
| Rtw Investments LP | 7.65% | 3,544,248 | $39.87M | Insider |
| Morgan Stanley | 7.28% | 3,370,362 | $37.92M | Institution |
| Lynx1 Capital Management LP | 6.39% | 2,956,918 | $33.27M | Institution |
| Redmile Group LLC | 5.67% | 2,625,506 | $29.54M | Institution |
STOK vs Biotech Stocks
Stoke Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.